Tempest Therapeutics Inc [TPST] stock prices are down -3.67% to $0.95 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TPST shares have gain 10.60% over the last week, with a monthly amount glided 3.79%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tempest Therapeutics Inc [NASDAQ: TPST] stock has seen the most recent analyst activity on March 14, 2024, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $13. Previously, Jefferies started tracking the stock with Buy rating on February 08, 2024, and set its price target to $15.
The stock price of Tempest Therapeutics Inc [TPST] has been fluctuating between $0.70 and $6.00 over the past year. Tempest Therapeutics Inc [NASDAQ: TPST] shares were valued at $0.95 at the most recent close of the market.
Analyzing the TPST fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.05, Equity is -1.87 and Total Capital is -1.79. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.81.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9069 points at the first support level, and at 0.8645 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9859, and for the 2nd resistance point, it is at 1.0225.
Ratios To Look Out For
It’s worth pointing out that Tempest Therapeutics Inc [NASDAQ:TPST]’s Current Ratio is 1.69. Further, the Quick Ratio stands at 1.69, while the Cash Ratio is 1.58.
Transactions by insiders
Recent insider trading involved Versant Venture Capital VI, L., Owner, that happened on Aug 12 ’24 when 0.39 million shares were purchased. 10% Owner, Versant Venture Capital VI, L. completed a deal on Aug 08 ’24 to sell 0.4 million shares. Meanwhile, 10% Owner Versant Venture Capital VI, L. sold 0.39 million shares on Aug 12 ’24.
